Edesa Biotech (EDSA) Tops Q2 EPS by 11c

Edesa Biotech (NASDAQ: EDSA) reported Q2 EPS of ($0.58), $0.11 better than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.

You May Also Be Interested In

• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $15 at Stifel
• ABM Industries (ABM) PT Raised to $51.50 at UBS, Neutral Rating Maintained